Madsen M W, Briand P
Laboratory of Tumor Endocrinology, Fibiger Institute, Copenhagen, Denmark.
Eur J Cancer. 1990;26(7):793-7. doi: 10.1016/0277-5379(90)90154-l.
Two human breast epithelial cell lines (HBL-100, HMT-3522) of non-malignant origin and six (MCF-7, T47-D, ZR-75-1, CAMA-1, BT-20, HMT-3909) of malignant origin have been studied to evaluate whether in vitro invasion and/or secretion of urokinase-type plasminogen activator are related to tumorigenicity in athymic nude mice. Only the six cell lines of malignant origin were tumorigenic. Two of these were invasive in the in vitro assay. These two cell lines were oestrogen receptor negative. Three of the other four cell lines of malignant origin contained oestrogen receptors. The two cell lines of non-malignant origin were neither tumorigenic nor invasive. Thus tumorigenicity was correlated to malignant origin of the cell line whereas invasiveness in vitro was a property of the most undifferentiated cell lines of tumor origin. Secretion of urokinase-type plasminogen activator was neither correlated to tumorigenicity nor to invasion in vitro nor to malignancy of tissue origin.
对两种非恶性来源的人乳腺上皮细胞系(HBL - 100、HMT - 3522)和六种恶性来源的细胞系(MCF - 7、T47 - D、ZR - 75 - 1、CAMA - 1、BT - 20、HMT - 3909)进行了研究,以评估体外侵袭和/或尿激酶型纤溶酶原激活剂的分泌是否与无胸腺裸鼠的致瘤性相关。只有六种恶性来源的细胞系具有致瘤性。其中两种在体外试验中具有侵袭性。这两种细胞系雌激素受体呈阴性。其他四种恶性来源的细胞系中有三种含有雌激素受体。两种非恶性来源的细胞系既无致瘤性也无侵袭性。因此,致瘤性与细胞系的恶性来源相关,而体外侵袭性是肿瘤来源的最未分化细胞系的特性。尿激酶型纤溶酶原激活剂的分泌既与致瘤性无关,也与体外侵袭性及组织来源的恶性程度无关。